$99.30
+8.28 (+9.10%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-87.1% upside
Low Target
$8.80
Average Target
$12.80
High Target
$18.52
Current Price
$99.30
Current
$99.30
$99.30
Target
$12.80
$12.80
$8.80
$12.80 avg
$18.52
Scenario Analysis
Bear Case
$8.80
-91.1%
Low target
Base Case
$12.80
-87.1%
Avg target
Bull Case
$18.52
+-81.3%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$104.00
-4.5% from high
52-Week Low
$15.83
+527.3% from low
Target vs 52W High
$12.80
-87.7% vs high
Next Earnings Report
Nov 12, 2026
3d
until earnings
EPS Est: $-1.07
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |